2015
DOI: 10.1038/ncomms9383
|View full text |Cite
|
Sign up to set email alerts
|

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families

Abstract: Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li–Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

6
122
0
8

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(136 citation statements)
references
References 45 publications
6
122
0
8
Order By: Relevance
“…These findings are consistent with the evidence of linkage of familial CLL to chromosomes 7q31.32-q33 and 16q12.2-q23.1 that we previously observed (supplemental Figure 5). 43 Germ line disruptive variants within shelterin genes have recently been implicated in predisposition to familial melanoma, 39,40 cardiac angiosarcoma, 44 glioma, 45 and colorectal cancer, 46 whereas somatic mutations of POT1 are detectable in 3.5% of all CLL and 9% of encoding immunoglobulin heavy chain variable-unmutated CLL, 37 and were also identified in 10% of patients with cutaneous T-cell lymphoma.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…These findings are consistent with the evidence of linkage of familial CLL to chromosomes 7q31.32-q33 and 16q12.2-q23.1 that we previously observed (supplemental Figure 5). 43 Germ line disruptive variants within shelterin genes have recently been implicated in predisposition to familial melanoma, 39,40 cardiac angiosarcoma, 44 glioma, 45 and colorectal cancer, 46 whereas somatic mutations of POT1 are detectable in 3.5% of all CLL and 9% of encoding immunoglobulin heavy chain variable-unmutated CLL, 37 and were also identified in 10% of patients with cutaneous T-cell lymphoma.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, in our case-control analysis, the POT1 p.Gln376Arg mutation was shown to confer a modest 3.6-fold increase in risk of CLL. Furthermore, the absence of significant LOH in the tumors of carriers, when examined, 44 suggests that mutations in the shelterin complex genes do not function as high penetrance tumor suppressors but rather as moderate penetrance alleles.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…13 In addition, the POT1 R117C variant has recently been identified as the cause of an inherited cancer syndrome in which loss of function causes an age-related increase in telomere length and genomic instability, contributing to the development of malignancies including lymphomas. 35 ATM is a PI3 kinase involved in the recognition of DNA double-strand breaks and recruitment of telomerase, and copy number losses have recently been reported in SS. 3,58 The ATM E2423K variant is associated with loss of function in non-small-cell lung cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have linked abnormally long telomeres to tumorigenesis [6, 8, 5659]. Interestingly, both FANCD2 and SLX4 localize to telomeres and are required for maintaining long telomeres in ALT cells.…”
Section: Discussionmentioning
confidence: 99%